HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Accupack Midwest Warning Letter

This article was originally published in The Rose Sheet

Executive Summary

Accupack Midwest Warning Letter: FDA cited "serious deviations" from GMPs for Accupack's SPF 15 lip balm in an April 23 warning letter. Among other deviations were the sale and distribution of two batches "without appropriate laboratory testing, including tests for the identity and strength of each active ingredient" and failure to establish and maintain appropriate records. The company, which has manufactured the product full-scale for about six months, said it has been in contact with FDA and will be in compliance by June 17...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts